Amid fear of Omicron covid variant spreading to numerous countries, the Centre has revised guidelines for transnational advents in India. The government has decided to review the resumption of transnational breakouts, introduced stricter guidelines for people travelling from or coursing through’at- threat’ countries After nearly two times, the government had on November 26 blazoned the resumption of listed transnational marketable breakouts from December 15. Breakouts are presently on under bilateral bubble arrangements with countries.
Passengers travelling from or coursing through’at- threat countries will have to suffer an RT-PCR test on appearance in India and will be needed to stay for the results before leaving the field or taking a connecting flight, according to revised guidelines issued by the Health Ministry. Trippers coming from countries other than those listed as’at- threat will be allowed to leave the field and shall tone- examiner their health for 14 days after appearance, but five per cent of them will be aimlessly tested at the field, it said.
New guidelines for transnational trip from 1 DecemberThe revised guidelines accreditation submitting 14 days’ trip details and uploading a negative RT-PCR test report on the Air Suvidha portal before the trip. The new rules will come into effect from 1 December till farther orders No case of Omicron covid variant in India so far
No cases of the variant, which was first reported to the World Health Organisation (WHO) from South Africa on November 24, have been recorded in India Alert to the brewing trouble from the’Omicron’variant, countries began tore-tighten checks and urgently trace people who arrived from abroad in the last one month. The Centre has asked all countries and UTs to concentrate on ferocious constraint, active surveillance, enhanced testing, monitoring of hotspots, increased content of vaccination and addition of health structure.
AIIMS Chief makes worrying statement on vaccine efficacity
According to a report in PTI, the new variant has the eventuality of developing”immunoescape mechanisms”which may lead to a dropped efficacity of COVID-19 vaccines, according to AIIMS Director Dr Randeep Guelria who said the efficacity of vaccines including those in use in India needs to be estimated”critically India, which battled the deadly alternate surge criticized on the Delta variant in April-May, faces the Omicron challenge after easing checks to a large extent following an enhancement in the situation.
Where has the Omicron Covid variant been spotted?
TheB.1.1.529 variant, designated as a”Variant of Concern”by WHO on Friday, has sparked a new surge of restrictions on trippers from colorful southern African nations by countries similar as the US, Canada, Brazil, Thailand, Indonesia, Singapore, Sri Lanka, the Maldives, Saudi Arabia, Brazil and the European Union.
